TipRanks
Advertisement
Advertisement
BillionToOne launches Northstar Origin, a new liquid biopsy test
PremiumThe FlyBillionToOne launches Northstar Origin, a new liquid biopsy test
1M ago
BillionToOne announces publication of study on cfDNA fetal risk assessment
Premium
The Fly
BillionToOne announces publication of study on cfDNA fetal risk assessment
2M ago
BillionToOne, Inc. Class A Signals Robust Growth
Premium
Company Announcements
BillionToOne, Inc. Class A Signals Robust Growth
2M ago
BillionToOne price target lowered to $130 from $145 at JPMorgan
PremiumThe FlyBillionToOne price target lowered to $130 from $145 at JPMorgan
2M ago
BillionToOne price target lowered to $130 from $142 at BTIG
Premium
The Fly
BillionToOne price target lowered to $130 from $142 at BTIG
2M ago
Closing Bell Movers: SiTime surges after quarterly results
Premium
The Fly
Closing Bell Movers: SiTime surges after quarterly results
2M ago
BillionToOne price target raised to $125 from $120 at Guggenheim
PremiumThe FlyBillionToOne price target raised to $125 from $120 at Guggenheim
4M ago
BillionToOne Stockholders Back Directors and Auditor at Meeting
Premium
Company Announcements
BillionToOne Stockholders Back Directors and Auditor at Meeting
4M ago
BillionToOne price target raised to $120 from $100 at Guggenheim
Premium
The Fly
BillionToOne price target raised to $120 from $100 at Guggenheim
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―